Status:
COMPLETED
Physical Activity in Multiple Sclerosis (MS): A Novel Approach to Study Outcomes
Lead Sponsor:
Kessler Foundation
Collaborating Sponsors:
University of Illinois at Urbana-Champaign
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18-64 years
Phase:
NA
Brief Summary
Physical activity and exercise interventions in multiple sclerosis (MS) have received great attention most recently and there exists several randomized clinical trials (RCTs) addressing the outcomes a...
Detailed Description
PROPOSAL NARRATIVE Specific Aims Specific Aim 1: Utilize innovative and objective measures/techniques (i.e., brain imaging, structured clinical interviews, performance based assessment of functional a...
Eligibility Criteria
Inclusion
- Diagnosis of multiple sclerosis (MS).
- Ability to read and speak English fluently.
- Ability to walk independently without the use of any assistive devices (e.g. cane, walker, or wheelchair).
Exclusion
- Left handedness
- Presence of a clip to repair a cerebral aneurysm (broken blood vessel in the head), cardiac pace-maker, cochlear implants (internal hearing aids) or metal fragments or pieces in eyes or any other part of body.
- Non MRI compatible metal in any part of body.
- Physician's instruction that it is medically unsafe for subject to receive regular MRI as part of their medical care.
- Engagement in the professions of painting or welding or other occupation that precludes an individual from getting a regular MRI.
- Proneness to claustrophobia (fear of enclosed spaces), to my knowledge.
- History of schizophrenia or bipolar disorder.
- Pregnancy
- History of stroke, brain Injury or neurological disease other than MS.
- Evidence of a flare up of MS symptoms within the past month.
- Administration of the following in last month: steroids, benzodiazepines, neuroleptics or opiates, as determined by the study doctor.
- History of significant psychiatric illness (for example, bipolar disorder, schizophrenia, or psychosis) or a current diagnosis of serious depression requiring treatment with medication,, Schizophrenia, Bipolar Disorder I or II.
- Significant alcohol or drug abuse history
Key Trial Info
Start Date :
November 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2016
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT02297932
Start Date
November 1 2014
End Date
June 1 2016
Last Update
August 18 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kessler Foundation
West Orange, New Jersey, United States, 07052